XBIOTECH INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
XBIOTECH INC. (XBIT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $172.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $172.00K, a 60.75% increase year-over-year.
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $172.00K, a 94.83% decline year-over-year.
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $162.00K, a 74.20% decline year-over-year.
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $24.00K, a 93.42% decline year-over-year.
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $3.62M, a 106.62% increase from fiscal 2024.
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.75M, a 46.26% decline from fiscal 2023.
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $3.26M, a 35.56% decline from fiscal 2022.
- XBIOTECH INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $5.06M, a 13.42% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $172.00K 10-Q · filed 2026-08-13 | $344.00K 10-Q · filed 2026-08-13 | $506.00K derived: sum of 3 quarters · filed 2026-08-13 | $530.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $172.00K 10-Q · filed 2026-05-14 | $334.00K derived: sum of 2 quarters · filed 2026-05-14 | $358.00K derived: sum of 3 quarters · filed 2026-05-14 | $465.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $186.00K derived: sum of 2 quarters · filed 2026-03-13 | $293.00K derived: sum of 3 quarters · filed 2026-08-13 | $3.62M 10-K · filed 2026-03-13 |
| 2025-09-30 | $24.00K 10-Q · filed 2025-11-12 | $131.00K derived: sum of 2 quarters · filed 2026-08-13 | $3.46M 10-Q · filed 2025-11-12 | $4.09M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $107.00K 10-Q · filed 2026-08-13 | $3.44M 10-Q · filed 2026-08-13 | $4.06M derived: sum of 3 quarters · filed 2026-08-13 | $4.43M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.33M 10-Q · filed 2026-05-14 | $3.96M derived: sum of 2 quarters · filed 2026-05-14 | $4.32M derived: sum of 3 quarters · filed 2026-05-14 | $4.70M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $993.00K derived: sum of 2 quarters · filed 2026-03-13 | $1.37M derived: sum of 3 quarters · filed 2026-03-13 | $1.75M 10-K · filed 2026-03-13 |
| 2024-09-30 | $365.00K 10-Q · filed 2025-11-12 | $744.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.13M 10-Q · filed 2025-11-12 | $1.81M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $379.00K 10-Q · filed 2025-08-13 | $760.00K 10-Q · filed 2025-08-13 | $1.45M derived: sum of 3 quarters · filed 2025-08-13 | $2.40M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $381.00K 10-Q · filed 2025-05-14 | $1.07M derived: sum of 2 quarters · filed 2025-05-14 | $2.02M derived: sum of 3 quarters · filed 2025-05-14 | $2.94M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.64M derived: sum of 2 quarters · filed 2025-03-18 | $2.56M derived: sum of 3 quarters · filed 2025-03-18 | $3.26M 10-K · filed 2025-03-18 |
| 2023-09-30 | $955.00K 10-Q · filed 2024-11-13 | $1.87M derived: sum of 2 quarters · filed 2024-11-13 | $2.57M 10-Q · filed 2024-11-13 | $3.61M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $914.00K 10-Q · filed 2024-08-12 | $1.62M 10-Q · filed 2024-08-12 | $2.66M derived: sum of 3 quarters · filed 2024-08-12 | $3.79M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $705.00K 10-Q · filed 2024-05-10 | $1.74M derived: sum of 2 quarters · filed 2024-05-10 | $2.87M derived: sum of 3 quarters · filed 2024-05-10 | $4.32M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $2.17M derived: sum of 2 quarters · filed 2024-03-15 | $3.61M derived: sum of 3 quarters · filed 2024-03-15 | $5.06M 10-K · filed 2024-03-15 |
| 2022-09-30 | $1.13M 10-Q · filed 2023-11-09 | $2.58M derived: sum of 2 quarters · filed 2023-11-09 | $4.02M 10-Q · filed 2023-11-09 | $5.38M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.45M 10-Q · filed 2023-08-11 | $2.90M 10-Q · filed 2023-08-11 | $4.25M derived: sum of 3 quarters · filed 2023-08-11 | $5.38M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.45M 10-Q · filed 2023-05-10 | $2.80M derived: sum of 2 quarters · filed 2023-05-10 | $3.94M derived: sum of 3 quarters · filed 2023-05-10 | $4.97M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.49M derived: sum of 2 quarters · filed 2023-03-15 | $3.53M derived: sum of 3 quarters · filed 2023-03-15 | $4.46M 10-K · filed 2023-03-15 |
| 2021-09-30 | $1.13M 10-Q · filed 2022-11-09 | $2.17M derived: sum of 2 quarters · filed 2022-11-09 | $3.11M 10-Q · filed 2022-11-09 | $5.90M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.04M 10-Q · filed 2022-08-10 | $1.98M 10-Q · filed 2022-08-10 | $4.77M derived: sum of 3 quarters · filed 2022-08-10 | $7.92M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $936.00K 10-Q · filed 2022-05-10 | $3.73M derived: sum of 2 quarters · filed 2022-05-10 | $6.88M derived: sum of 3 quarters · filed 2022-05-10 | $10.06M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $5.95M derived: sum of 2 quarters · filed 2022-03-15 | $9.13M derived: sum of 3 quarters · filed 2022-03-15 | $12.58M 10-K · filed 2022-03-15 |
| 2020-09-30 | $3.15M 10-Q · filed 2021-11-09 | $6.33M derived: sum of 2 quarters · filed 2021-11-09 | $9.79M 10-Q · filed 2021-11-09 | $11.29M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $3.18M 10-Q · filed 2021-08-09 | $6.63M 10-Q · filed 2021-08-09 | $8.14M derived: sum of 3 quarters · filed 2022-03-15 | $8.93M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $3.46M 10-Q · filed 2021-05-10 | $4.96M derived: sum of 2 quarters · filed 2022-03-15 | $5.76M derived: sum of 3 quarters · filed 2022-03-15 | $6.24M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.30M derived: sum of 2 quarters · filed 2022-03-15 | $2.79M derived: sum of 3 quarters · filed 2022-03-15 | $3.36M 10-K · filed 2022-03-15 |
| 2019-09-30 | $797.00K 10-Q · filed 2020-11-09 | $1.28M derived: sum of 2 quarters · filed 2020-11-09 | $1.85M 10-Q · filed 2020-11-09 | $2.33M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $486.00K 10-Q · filed 2020-08-10 | $1.06M 10-Q · filed 2020-08-10 | $1.53M derived: sum of 3 quarters · filed 2021-03-16 | $1.97M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $570.00K 10-Q · filed 2020-05-11 | $1.04M derived: sum of 2 quarters · filed 2021-03-16 | $1.48M derived: sum of 3 quarters · filed 2021-03-16 | $2.12M derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $912.00K derived: sum of 2 quarters · filed 2021-03-16 | $1.55M derived: sum of 3 quarters · filed 2021-03-16 | $1.66M 10-K · filed 2021-03-16 |
| 2018-09-30 | $438.00K 10-Q · filed 2019-11-12 | $1.08M derived: sum of 2 quarters · filed 2019-11-12 | $1.19M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $638.00K 10-Q · filed 2019-08-09 | $748.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $110.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $1.64M 10-K · filed 2020-03-16 | |||
| 2016-12-31 | $5.57M 10-K/A · filed 2019-03-15 | |||
| 2015-12-31 | $4.41M 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $7.02M 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $739.00K 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |